These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4624926)
1. [Long-term treatment of schizophrenic psychoses using retard-neuroleptic preparations]. Andreas W Med Welt; 1972 Apr; 23(15):566-7. PubMed ID: 4624926 [No Abstract] [Full Text] [Related]
2. [Long-term treatment with neuroleptics in schizophrenic and paraphrenic psychoses]. König L Z Arztl Fortbild (Jena); 1977 Apr; 71(8):410-4. PubMed ID: 878514 [No Abstract] [Full Text] [Related]
3. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")]. Bohacek N; Mihovilović M Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835 [No Abstract] [Full Text] [Related]
4. Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment. Wintrob RM Dis Nerv Syst; 1970 Sep; 31():Suppl:50-62. PubMed ID: 4990944 [No Abstract] [Full Text] [Related]
5. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)]. Haumonté MT; Hoerdt HP Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257 [No Abstract] [Full Text] [Related]
6. [Experience with the depot neuroleptic LyogenR-depot]. Bach O; Petermann H; Geppert V Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993 [TBL] [Abstract][Full Text] [Related]
7. Fluphenazine enanthate given to inpatients and outpatients. Lambert PA; Marcou G Dis Nerv Syst; 1970 Sep; 31():Suppl:63-5. PubMed ID: 4990945 [No Abstract] [Full Text] [Related]
9. [Long-acting neuroleptic preparations and their use in mental disorders]. Vovin RIa; Vovina EN Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):920-4. PubMed ID: 5050052 [No Abstract] [Full Text] [Related]
10. [Current status of neuroleptic long term treatment of schizophrenia]. Woggon B; Angst J; Margoses N Nervenarzt; 1975 Nov; 46(11):611-6. PubMed ID: 813157 [No Abstract] [Full Text] [Related]
11. [Statistical method of analysis and evaluation of therapeutic results in psychiatry. Example of application to a delayed-action neuroleptic and comparison with a standard neuroleptic and with Sakel's insulin treatment]. Gayral L; Caussinus H; Schecktman Y Therapie; 1970; 25(1):29-42. PubMed ID: 5436802 [No Abstract] [Full Text] [Related]
12. [Modification of long-term schizophrenia by somato-therapeutic measures]. Gross G; Huber G; Schüttler R Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621 [TBL] [Abstract][Full Text] [Related]
13. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. Wiles DH; Gelder MG Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678 [No Abstract] [Full Text] [Related]
14. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)]. Polácek J Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182 [No Abstract] [Full Text] [Related]
16. [Therapeutic trial with a long-acting phenothiazine derivative. Fluphenazine enanthate in a group of chronic schizophrenics]. Mariátegui J; Alarcón R; Arana J; Azcárate C; Butler A Rev Neuropsiquiatr; 1966 Mar; 29(1):33-44. PubMed ID: 5940303 [No Abstract] [Full Text] [Related]
17. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate]. Auch W Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981 [No Abstract] [Full Text] [Related]
18. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445 [No Abstract] [Full Text] [Related]
19. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients]. La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572 [No Abstract] [Full Text] [Related]
20. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?]. Müller P Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720 [No Abstract] [Full Text] [Related] [Next] [New Search]